2666-9676

Journal of Liver Transplantation

Elsevier

View prefix report (10.1016)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 315 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact315 DOIs
2

Attach ORCID iDs across 126 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact126 DOIs
3

Deposit reference lists for 44 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact44 DOIs

DOIs for this ISSN

Showing the top 5 of 315 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Deep learning technique for automatic liver and liver tumor… (10.1016/j.liver.2024.100251)
Abstract ORCID
76.57 33
2 Is bariatric surgery safer before, during, or after liver tr… (10.1016/j.liver.2023.100139)
Abstract ORCID
66.11 20
3 Automatic liver tumor classification using UNet70 a deep lea… (10.1016/j.liver.2025.100260)
Abstract ORCID
61.52 16
4 Automated segmentation of liver tumors from computed tomogra… (10.1016/j.liver.2024.100232)
Abstract ORCID
57.31 13
5 Current techniques and future trends in the diagnosis of hep… (10.1016/j.liver.2022.100091)
Abstract ORCID
55.70 12
6 COVID-19 in liver transplant recipients (10.1016/j.liver.2021.100026)
Abstract ORCID
52.07 10
7 Surgical anatomy of segment four of liver and its implicatio… (10.1016/j.liver.2022.100076)
Abstract ORCID
47.71 8
8 Challenges in liver transplantation for common variable immu… (10.1016/j.liver.2021.100038)
Abstract ORCID
45.15 7
9 The importance of Inferior Hepatic vein reconstruction in ri… (10.1016/j.liver.2021.100025)
Abstract ORCID
42.25 6
10 Integration of addiction treatment and behavioral therapies… (10.1016/j.liver.2021.100061)
Abstract ORCID
38.91 5
11 Treatment of refractory ascites with an automated low flow a… (10.1016/j.liver.2021.100037)
Abstract ORCID
34.95 4
12 Impact of COVID-19 on 2020 transplant activity and waiting l… (10.1016/j.liver.2021.100051)
Abstract ORCID
34.95 4
13 Investigating Ineligibility of Potential Living Liver Donors… (10.1016/j.liver.2023.100163)
Abstract ORCID
34.95 4
14 Post-liver transplantation GVHD: time to consider histocompa… (10.1016/j.liver.2021.100021)
Abstract ORCID
30.10 3
15 Current management & future directions in post-liver tra… (10.1016/j.liver.2021.100027)
Abstract ORCID
30.10 3
16 Post COVID-19 mucormycosis in liver transplant recipients-Wa… (10.1016/j.liver.2021.100033)
Abstract ORCID
30.10 3
17 Co-infection with SARS-CoV-2 and Pneumocystis jirovecii in l… (10.1016/j.liver.2021.100047)
Abstract ORCID
30.10 3
18 Liver transplantation-associated lung cancer in smokers: Res… (10.1016/j.liver.2021.100050)
Abstract ORCID
30.10 3
19 Nutritional therapy to cirrhotic patients on transplantation… (10.1016/j.liver.2021.100060)
Abstract ORCID
30.10 3
20 Cardiopulmonary assessment of patients with unresectable hep… (10.1016/j.liver.2021.100063)
Abstract ORCID
30.10 3
21 Treatment of Portopulmonary Hypertension (PoPH): A review (10.1016/j.liver.2022.100071)
Abstract ORCID
30.10 3
22 Gut microbiota might influence the risk of rejection after l… (10.1016/j.liver.2023.100140)
Abstract
26.98 11
23 Donor-specific antibodies and their impact on antibody-media… (10.1016/j.liver.2024.100214)
Abstract
26.03 10
24 Repeated COVID-19 infection in recipients of post-living don… (10.1016/j.liver.2021.100002)
Abstract ORCID
23.86 2
25 Sinusoidal obstruction syndrome after liver transplantation:… (10.1016/j.liver.2021.100018)
Abstract ORCID
23.86 2
26 High prevalence of asymptomatic SARS-CoV-2 infection in a co… (10.1016/j.liver.2021.100064)
Abstract ORCID
23.86 2
27 Life expectancy after liver transplantation for hepatitis C… (10.1016/j.liver.2021.100069)
Abstract ORCID
23.86 2
28 Life expectancy after liver transplantation: Compendium of r… (10.1016/j.liver.2022.100082)
Abstract ORCID
23.86 2
29 Hemodynamic monitoring in liver Transplantation patients in… (10.1016/j.liver.2023.100156)
Abstract ORCID
23.86 2
30 Vascular thrombosis after pediatric liver transplantation: I… (10.1016/j.liver.2023.100185)
Abstract
22.58 7
31 Contents (10.1016/s2666-9676(23)00008-9)
Abstract References ORCID
22.58 1
32 Living donor left lateral sectionectomy: Should the procedur… (10.1016/j.liver.2020.100001)
Abstract
21.13 6
33 Risk factors for 30-day readmission following liver transpla… (10.1016/j.liver.2022.100114)
Abstract
21.13 6
34 Accuracy of preoperative liver volumetry in living donor liv… (10.1016/j.liver.2023.100150)
Abstract
21.13 6
35 Early liver transplantation for severe alcohol-associated he… (10.1016/j.liver.2023.100184)
Abstract
21.13 6
36 HBV/HDV management after liver transplantation: Review (10.1016/j.liver.2021.100046)
Abstract
19.45 5
37 Inferior Liver Transplant Outcomes during early COVID-19 pan… (10.1016/j.liver.2022.100099)
Abstract
19.45 5
38 Obligation and the “Gift of Life”: Understanding frictions s… (10.1016/j.liver.2022.100102)
Abstract
19.45 5
39 Anesthesia and enhanced recovery for robotic living donor he… (10.1016/j.liver.2023.100148)
Abstract
19.45 5
40 Assessment and management of patients with portopulmonary hy… (10.1016/j.liver.2023.100169)
Abstract
19.45 5
41 Outcomes of patients with primary sclerosing cholangitis aft… (10.1016/j.liver.2023.100186)
Abstract
19.45 5
42 Cardiovascular assessment of candidates for liver transplant (10.1016/j.liver.2023.100153)
Abstract
17.47 4
43 A revealing scandal: The German transplant scandal between s… (10.1016/j.liver.2023.100168)
Abstract
17.47 4
44 Layered Methodologies: Innovating Multimodal Qualitative Res… (10.1016/j.liver.2023.100183)
Abstract
17.47 4
45 The effects of underlying inflammatory bowel disease on the… (10.1016/j.liver.2024.100244)
Abstract
17.47 4
46 Immunotherapy in liver transplantation for hepatocellular ca… (10.1016/j.liver.2024.100256)
Abstract
17.47 4
47 Alpha-1 antitrypsin deficiency-associated liver disease: A r… (10.1016/j.liver.2025.100287)
Abstract
17.47 4
48 Surgical outcomes after donor hepatectomy for adult living-d… (10.1016/j.liver.2021.100023)
Abstract ORCID
15.05 1
49 Interleukin-2 receptor antibody induction with early low dos… (10.1016/j.liver.2021.100028)
Abstract ORCID
15.05 1
50 Plasmablastic lymphoma as post transplant lymphoproliferativ… (10.1016/j.liver.2021.100036)
Abstract ORCID
15.05 1